ITT | PP | |||||
---|---|---|---|---|---|---|
Efficacy evaluation | ||||||
No PCR correction | n | % | 95% CI | N | % | 95% CI |
AL | 138 | 80.4 | 72.6-86.4 | 123 | 91 | 84.2-95.2 |
ASAQ | 279 | 81.4 | 76.1-85.7 | 255 | 89.4 | 84.8-92.7 |
DHAP | 280 | 80.4 | 75.1-85.7 | 245 | 89.4 | 84.6-92.8 |
PCR corrected | ||||||
AL | 138 | 92 | 85.9-95.7 | 123 | 96.7 | 91.3-98.9 |
ASAQ | 279 | 91 | 89.3-95.7 | 255 | 98.1 | 95.2-99.2 |
DHAP | 280 | 89 | 85.3-92.8 | 245 | 96.3 | 92.9-98.2 |